Article
Induction of a SALL4-dependency for targeted cancer therapy
2020-07-11
Abstract excerpt
Oncofetal protein SALL4 is critical for tumor cell survival, making it a promising target in cancer therapy. However, it is detectable only in a subset of cancer patients, which limits the therapeutic impact of a SALL4 targeted therapy. Here we report that SALL4 can be activated and/or upregulated pharmacologically by hypomethylating agents, such as 5-Aza-2’-deoxycytidine (DAC), which are used clinically, and that...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 74bd54b1-2218-5eed-86a5-86abf4b158ec
- DOI
- 10.1101/2020.07.10.197434
